Discover our impact all over the world.

Numbers displayed on the map are a representation of the activity in each country. Once you use the filter selections below, you will have the opportunity to explore projects and faculty in each country.

Projects + Faculty = Activity Number

##

Overview

Projects 285
Countries 141
Faculty 358
Health Topics 122

Filter from the selections below

Clear All Filters
Back to search

Multi-center, Randomized, Double-blind, Placebo-controlled Phase 3 Efficacy Study of a Heterologous Vaccine Regimen of Ad26.Mos4.HIV and Adjuvanted Clade C gp140 and Mosaic gp140 to Prevent HIV-1 Infection Among Cis-gender Men and transgender Individuals

To evaluate the vaccine efficacy (VE) of a
heterologous vaccine regimen utilizing Ad26.Mos4.HIV and aluminum phosphateadjuvanted Clade C gp140 and Mosaic gp140 for the prevention of HIV-1 infection in HIV-1 seronegative cis-gender men and transgender individuals having sex with cis-gender men and/or transgender individuals.

Active Dates 
01/01/2020 to 09/30/2023
Faculty Involved 
Health Topics